FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Stock

Certificat

DE000JK5DSP9

Market Closed - Börse Stuttgart 11:57:00 2024-06-28 EDT
6.79 EUR +12.42% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-85.35%
1 month-83.37%
Date Price Change
24-06-28 6.79 +12.42%
24-06-27 6.04 +3.78%
24-06-26 5.82 +3.56%
24-06-25 5.62 -41.15%
24-06-24 9.55 +1.17%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 11:57 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK5DSP
ISINDE000JK5DSP9
Date issued 2024-03-22
Strike 33.7 $
Maturity Unlimited
Parity 1.18 : 1
Emission price 10.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 46.43
Lowest since issue 4.3
Spread 0.7
Spread %10.92%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.29 USD
Average target price
49.93 USD
Spread / Average Target
+23.93%
Consensus